Chesnara Plc: Fourth acquisition in two years
12 November 2026
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, has captured investor attention with a potential upside of 25.60%, despite facing significant..
Fulgent Genetics, Inc. (NASDAQ: FLGT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $525.3 million, the..
Cross Country Healthcare, Inc. (NASDAQ: CCRN), a leading player in the healthcare staffing industry, is currently at a pivotal juncture that investors are keenly observing. With..
Cronos Group Inc. (CRON), a prominent player in the cannabinoid sector, engages in the cultivation, production, distribution, and marketing of cannabis products across several markets, including..
Tyra Biosciences, Inc. (NASDAQ: TYRA) is making significant waves in the biotechnology sector, with a market capitalization of $2.13 billion as it spearheads the development of..
LifeMD, Inc. (NASDAQ: LFMD) is navigating the healthcare landscape with a distinct focus on telehealth services. Despite facing some financial hurdles, the company’s potential for significant..
Investors with a keen eye for opportunities in the biotechnology sector might find Arvinas, Inc. (NASDAQ: ARVN), a compelling stock to watch. Specializing in the discovery..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is carving a niche in the healthcare sector, specifically in biotechnology, where it focuses on developing treatments for various cancers. Based..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a Massachusetts-based biopharmaceutical company, is garnering attention in the biotechnology sector thanks to its promising pipeline and strong analyst endorsements. With..
Investors eyeing the healthcare sector should consider the dynamics of Enhabit, Inc. (NASDAQ: EHAB), a company that stands at the intersection of home health and hospice..
Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a promising player in the biotechnology sector, is capturing investor attention with a compelling forecasted upside of 48.55%. With a market..
Bicara Therapeutics Inc. (NASDAQ: BCAX) is capturing investor attention with its robust market potential and promising outlook in the biotechnology sector. With a market capitalization of..
Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector with its impressive revenue growth and strategic partnerships. Based in South San Francisco, California, this..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company based in Deer Park, Illinois, has been making waves in the healthcare sector with its focus on..
RxSight, Inc. (NASDAQ: RXST) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Aliso Viejo, California, the company focuses..
Arcus Biosciences, Inc. (NASDAQ: RCUS) is capturing the attention of investors with its promising pipeline of cancer therapies and a compelling potential upside of 47.21%, as..
AnaptysBio, Inc. (NASDAQ: ANAB) is capturing investor attention with an impressive potential upside of 38.22%, as suggested by its average target price. As a clinical-stage biotechnology..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling opportunity in the healthcare sector, particularly within the dynamic biotechnology industry. With a market capitalization of $1.08..
For investors eyeing opportunities in the healthcare sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents a compelling case with a significant 210.50% potential upside, according to recent..
